AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Price, Forecast & Analysis
USA - NASDAQ:AZYO - US05479K1060 - Common Stock
AZYO Key Statistics, Chart & Performance
The current stock price of AZYO is 1.49 USD. In the past month the price decreased by -1.97%. In the past year, price decreased by -79.62%.
AZYO Latest News, Press Relases and Analysis
AZYO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.58 | 410.35B | ||
| AMGN | AMGEN INC | 15.36 | 180.89B | ||
| GILD | GILEAD SCIENCES INC | 15.29 | 155.35B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.03 | 111.41B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.44 | 73.66B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 890.14 | 59.51B | ||
| INSM | INSMED INC | N/A | 40.36B | ||
| NTRA | NATERA INC | N/A | 27.54B | ||
| BIIB | BIOGEN INC | 9.84 | 24.15B | ||
| INCY | INCYTE CORP | 16.42 | 20.58B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.52 | 20.91B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 34.49 | 14.30B |
Related stock screener links
About AZYO
Company Profile
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
Company Info
AZIYO BIOLOGICS INC-CLASS A
12510 Prosperity Drive, Suite 370
Silver Spring MARYLAND 20904 US
CEO: Ronald Lloyd
Employees: 151
Phone: 12402471143.0
AZIYO BIOLOGICS INC-CLASS A / AZYO FAQ
What does AZYO do?
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
What is the stock price of AZIYO BIOLOGICS INC-CLASS A today?
The current stock price of AZYO is 1.49 USD. The price increased by 2.05% in the last trading session.
What is the dividend status of AZIYO BIOLOGICS INC-CLASS A?
AZYO does not pay a dividend.
What is the ChartMill rating of AZIYO BIOLOGICS INC-CLASS A stock?
AZYO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is AZIYO BIOLOGICS INC-CLASS A (AZYO) stock traded?
AZYO stock is listed on the Nasdaq exchange.
Can you provide the market cap for AZIYO BIOLOGICS INC-CLASS A?
AZIYO BIOLOGICS INC-CLASS A (AZYO) has a market capitalization of 24.21M USD. This makes AZYO a Nano Cap stock.
What is the ownership structure of AZIYO BIOLOGICS INC-CLASS A (AZYO)?
You can find the ownership structure of AZIYO BIOLOGICS INC-CLASS A (AZYO) on the Ownership tab.
AZYO Technical Analysis
AZYO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AZYO. AZYO may be in some trouble as it scores bad on both profitability and health.
AZYO Financial Highlights
Over the last trailing twelve months AZYO reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 22.95% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AZYO Forecast & Estimates
7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.
For the next year, analysts expect an EPS growth of 9.47% and a revenue growth -12.95% for AZYO